Published in
BMJ Publishing Group, Annals of the Rheumatic Diseases, 3(82), p. e58-e58, 2021
DOI: 10.1136/annrheumdis-2020-219721
Links
Tools
Response to: ‘Correspondence on “Glucosamine and O-GlcNAcylation: a novel immunometabolic therapeutic target for OA and chronic, low-grade systemic inflammation?’ by Angelides and Manolios
Journal article published in 2021 by
Gabriel Herrero-Beaumont 
,
Raquel Largo
,
Raquel Largo
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 